Table 1.

Pretreatment Patient Characteristics by Treatment Group

Characteristic	RT + FU + Mitomycin (n = 472)		RT + FU + Cisplatin (n = 320)		RT + FU (n = 145)		P†
	No.	%	No.	%	No.	%
Age, years
Median	57		55		59		—
Range	25-85		31-88		26-86
Sex
Male	145	31	97	30	56	39	.16
Female	327	69	223	70	89	61
T stage
T1/T2	288	61	212	66	72	50	.003
T3/T4	184	39	108	34	73	50
N stage
N0	350	74	221	69	119	82	.01
NX/N1/N2/N3	122	26	99	31	26	18
KPS
60, 70, 80	84	18	52	16	33	23	.24
90, 100	388	82	268	84	112	77
Histology
Squamous	397	84	273	85	116	80	.27
Nonsquamous	72	15	47	15	27	19
Unknown	3	1	0	0	2	1
Differentiation
Low/intermediate grade	230	49	166	52	68	47	.54
High grade	140	30	96	30	41	28
Unknown	102	22	58	18	36	25

Abbreviations: RT, radiation therapy; FU, fluorouracil; KPS, Karnofsky performance score.

^†P value from the χ² test.